Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients

Although the prognosis of leukemia patients after allogeneic hematopoietic stem cell transplantation (HSCT) has greatly improved, relapse is still a major cause of death after HSCT. Cancer vaccines may have the potential to enhance the graft-versus-leukemia (GVL) effect. The post–allogeneic HSCT per...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Investig
Main Authors: Hosen, Naoki, Maeda, Tetsuo, Hashii, Yoshiko, Tsuboi, Akihiro, Nishida, Sumiyuki, Nakata, Jun, Oji, Yusuke, Oka, Yoshihiro, Sugiyama, Haruo
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5222711/
https://ncbi.nlm.nih.gov/pubmed/28078270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2016.11.08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados